US death row inmate executed with new drug

Image
IANS Washington
Last Updated : Aug 25 2017 | 12:13 PM IST

Florida has executed an inmate for the first time in more than 18 months, administering a lethal injection drug that had not previously been used in the US, the media reported.

Mark Asay, 53, was executed at 6.22 p.m. (local time) on Thursday without any incident, CNN quoted Florida corrections officials as saying.

Asay had no last statement, and did not speak or show any indication of pain during the execution. His demeanour earlier in the morning was calm, a Florida corrections department spokeswoman said.

The US Supreme Court earlier on Thursday denied a stay of execution request for Asay.

He was convicted in 1988 of the racially motivated murders of two men in Jacksonville the previous year.

A jury found him guilty of killing Robert Lee Booker -- who was black -- and Robert McDowell.

Before he shot Booker, he called him a racial epithet, CNN reported.

The execution marked Florida's first since a US Supreme Court ruling temporarily halted the practice in early 2016, saying the state's sentencing process was unconstitutional because it gave judges, rather than juries, too much power in deciding whether to execute an inmate.

The state used etomidate as one of three drugs in the lethal injection, marking the first time the sedative has been used in an execution.

Etomidate will be a substitute for midazolam, a drug that has become harder to get because some drug manufacturers do not want it used in executions.

--IANS

ksk/vm

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Aug 25 2017 | 12:04 PM IST

Next Story